🔎 Trials Near Me

Akèy › Maladi fwa steatotik › Kalifòni › Pasadena

Etid klinik pou Maladi fwa steatotik nan Pasadena, CA

8 etid pou Maladi fwa steatotik ap chèche patisipan nan sit nan ak bò kote Pasadena (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Ap rekriteFaz 3
  • 89bio Clinical Study Site, Pasadena
Laj 18 a 75 · Tout sèks · Mizajou Oct 5, 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Ap rekriteFaz 3
  • 89bio Clinical Study Site, Pasadena
Laj 18 a 80 · Tout sèks · Mizajou Oct 5, 2026 · NCT06318169

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Ap rekriteFaz 2
  • California Liver Research Institute, Pasadena
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07527910

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Ap rekriteFaz 3
  • California Liver Research Center, Pasadena
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Ap rekriteFaz 3
  • Akero Clinical Study Site, Pasadena
Laj 18 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT06528314

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

Ap rekriteFaz 2
  • GSK Investigational Site, Pasadena
Laj 18 a 70 · Tout sèks · Mizajou Aug 3, 2026 · NCT06613698

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Ap rekriteFaz 2
  • GSK Investigational Site, Pasadena
Laj 18 a 75 · Tout sèks · Mizajou Jul 8, 2026 · NCT06920043

Etid Maladi fwa steatotik nan lòt vil

Lòt etid nan Pasadena

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.